Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ina Inaridze"'
Autor:
Tamar Kikvidze, Konstantine Labartkava, Niklas Luhmann, George Kamkamidze, Aurélie Etienne, Julie Bouscaillou, Elisabeth Avril, David Kharshiladze, Diane Le Pluart, Ina Inaridze, Maia Butsashvili, Ana Gamezardashvili
Publikováno v:
International Journal of Drug Policy. 62:104-111
Background People who inject drugs (PWID) are often excluded from HCV treatment programs due to concerns about their ability to adhere to care. Georgia has a high prevalence of HCV infection (5.4% of chronic cases in general population) with an epide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87dfc8f3af7b589905d9c6baeec2fc57
https://doi.org/10.1016/j.drugpo.2018.07.016
https://doi.org/10.1016/j.drugpo.2018.07.016
Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia
Autor:
Konstantine Labartkava, Elisabeth Avril, Maia Butsashvili, Niklas Luhmann, Tamar Kikvidze, David Kharshiladze, Julie Bouscaillou, Aurélie Etienne, Diane Le Pluart, Ina Inaridze, Ana Gamezardashvili
Publikováno v:
International Journal of Drug Policy. 52:16-19
Backgrounds Georgia faces high HCV rates (5.4% of chronic cases in general population) with an epidemic concentrated among people who inject drugs (PWID). A National HCV Elimination Program (NHCEP), was launched in April 2015, aiming to eliminate HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6d093ea242bf86d55b9930d33a0d4e
https://doi.org/10.1016/j.drugpo.2017.11.014
https://doi.org/10.1016/j.drugpo.2017.11.014
Autor:
Dominique Pataut, Koka Labartkava, George Kamkamidze, Maia Butsashvili, Elisabeth Avril, Julie Bouscaillou, Niklas Luhmann, Irma Kirtadze, Veronique Miollany, Ina Inaridze, Julie Champagnat
Publikováno v:
International Journal of Drug Policy. 25:871-878
Background Drug use and hepatitis C virus (HCV) are both major public health issues in Georgia. However, the access to HCV prevention and care is still very limited in the country. This study was conducted to examine the HCV epidemic among people who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee38e8c1f66d5d4f68f78814cf08fc44
https://doi.org/10.1016/j.drugpo.2014.01.007
https://doi.org/10.1016/j.drugpo.2014.01.007
Autor:
Wai Moe Myint, Ina Inaridze, Ludmila Maistat, Sergey Golovin, Julie Bouscaillou, Julie Champagnat, Maia Butsashvili, Edo Agustian, Niklas Luhmann
Publikováno v:
The International journal on drug policy. 26(11)
Background People who inject drugs (PWID) are disproportionately affected by the hepatitis C (HCV) epidemic. Of the estimated 16 million PWID worldwide, approximately 8 million live with chronic HCV, and around 26% and 23% of the global HCV infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5139b5aada2223208875e40788996245
https://pubmed.ncbi.nlm.nih.gov/26342273
https://pubmed.ncbi.nlm.nih.gov/26342273
Autor:
Konstantine Labartkava, Elisabeth Avril, Maia Butsashvili, Tamar Kikvidze, Julie Bouscaillou, Niklas Luhmann, Ana Gamezardashvili, George Kamkamidze, Ina Inaridze, Aurélie Etienne
Publikováno v:
Journal of Hepatology. 66:S409
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebbadcb21d3f5f25dbcb8f497e5ec847
https://doi.org/10.1016/s0168-8278(17)31177-7
https://doi.org/10.1016/s0168-8278(17)31177-7